No photos found.
Too early to stay. I reckon there's a lot of IHT funds selling ahead of the main market move.
This user has no comment yet.
No profile data added yet. |
No photos found.
Too early to stay. I reckon there's a lot of IHT funds selling ahead of the main market move.
Actually ARR isn't that great. The issue with CER has always been that most of their revenues are hourly billing for implementations/upgrades. Only
Quite possibly, but it puts the PE around 15x which is probably about right given California expires in 12/27.
They say the EBITDA margins will drop from the exceptional 23.7% this year to the target mid-teens next year. Doesn't that mean earnings will drop by
I've had the funds through from Interactive Investor. Nothing from HL yet.
No from II or from HL.
I think it's only pharma that are exempt. Medical devices do have the new tariff levels. I know they outsource manufacturing but I can't find where
Your'e right on the displacement of workers.
Not really comparable IMHO. Nvidia is in the middle of an AI capex bubble which many commentators think is unsustainable.
Yes Cavs upgrade FY25 by 6% to 5.4p from 5.1p. They've kept FY26 at 4.4p but that assumes no interest income from the cash pile and will be a base
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions